University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)

dc.contributor.authorPiraino, Alessio
dc.contributor.authorBrusselle, Guy
dc.contributor.authorGrainge, Christopher
dc.contributor.authorRoche, Nicolas
dc.contributor.authorGayle, Alicia
dc.contributor.authorCarter, Victoria
dc.contributor.authorPrice, David
dc.contributor.authorDi Palma, Luca
dc.contributor.authorSingh, Dave
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2025-08-26T10:41:01Z
dc.date.available2025-08-26T10:41:01Z
dc.date.issued2025-05
dc.description.statusPeer revieweden
dc.format.extent2
dc.format.extent141720
dc.identifier308269858
dc.identifier77851089-da8f-49f4-b438-b8e602398e6c
dc.identifier.citationPiraino, A, Brusselle, G, Grainge, C, Roche, N, Gayle, A, Carter, V, Price, D, Di Palma, L & Singh, D 2025, 'The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)', American Journal of Respiratory and Critical Care Medicine, vol. 211, no. Abstracts, A1474. https://doi.org/10.1164/ajrccm.2025.211.Abstracts.A1474en
dc.identifier.doi10.1164/ajrccm.2025.211.Abstracts.A1474
dc.identifier.issn1073-449X
dc.identifier.urihttps://hdl.handle.net/2164/25915
dc.identifier.vol211en
dc.language.isoeng
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleThe BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)en
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Price_etal_ATS_The_BETRI_Study_AAM.pdf
Size:
138.4 KB
Format:
Adobe Portable Document Format

Collections